UNOS and HRSA agree on new short-term OPTN contract
Contract goes into effect March 30, 2024, the day after the current contract concludes
UNOS welcomes new seven-member board of directors
New seven-person UNOS Board will be independent of OPTN Board March 30
UNOS applauds president’s FY2025 budget request
Statement applauding President Biden’s budget proposal which includes $67 million to fund HRSA’s OPTN Modernization Initiative
UNOS expands leadership team
Tina Rhoades promoted to director of patient and member relations
UNOS statement on member vote for board independence
Statement about member vote to ratify the UNOS Board of Directors’ vote for board independence
UNOS statement regarding Medicare billing guidance for organ transplant monitoring tests
UNOS statement regarding the Medicare billing guidance on molecular testing for solid organ allograft rejection